Evidence map›Paper›PMID 39984575›Full record

Observational studyScientific reports2025

Changes in the spectrum of ocular disease during the COVID-19 pandemic in late 2022 in the Hubei Province.

Qing Bao, Yanru Shen, Zhiwei Zheng, Yan Zheng, Yuting Li, Yaoyao Ren, Nan Zhang, Xiaomin Chen, Min Ke

Abstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qing Bao *Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yanru Shen *Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhiwei ZhengDepartment of Ophthalmology, Qichun People's Hospital, Huanggang, Hubei, China.
Yan ZhengDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yuting LiDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yaoyao RenDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Nan ZhangDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xiaomin ChenDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China. xminchen@whu.edu.cn.
Min KeDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China. keminyk@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to investigate changes in the ocular disease spectrum during the coronavirus disease-2019 (COVID-19) pandemic in late 2022 in the Hubei Province. This retrospective observational study was conducted in two parts. The first part involved collecting COVID-19-related information from residents of Hubei Province through an online questionnaire survey. The second part involved extracting electronic medical records from ophthalmology outpatient departments at two hospitals in Hubei Province during the pandemic and epidemic prevention and control periods, analyzing changes in the spectrum of ocular diseases. In the first part, 31.65% of patients with systemic symptoms of COVID-19 experienced ocular discomfort. The most common ocular symptoms were eye fatigue, ocular pain and dry eye. In the second part, 76.5% of patients who visited the ophthalmic clinic had COVID-19-related systemic symptoms during pandemic period. The proportion of patients with cornea/keratitis, glaucoma/acute angle-closure glaucoma (AACG) and vitreoretinal disease/retinal vein obstruction (RVO)/acute macular neuroretinalpathy (AMN) increased markedly during pandemic period. Additionally, the number of patients under 18 years and over 60 years decreased significantly compared to the same age groups pre- & post-pandemic. The COVID-19 pandemic has led to certain changes in the spectrum of ocular diseases, which warrants the attention of ophthalmologists.

Indexed as

COVID-19Eye DiseasesAdolescentAdultAgedAged, 80 and overChinaFemaleHumansMaleMiddle AgedPandemicsRetrospective StudiesSARS-CoV-2Surveys and QuestionnairesYoung AdultAcute angle-closure glaucomaAcute macular neuroretinalpathyCOVID-19 pandemicKeratitisOcular diseaseRetinal vein obstruction

Identifiers

PMID39984575
PMCPMC11845709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.